company background image
DMP logo

Dermapharm Holding XTRA:DMP Stock Report

Last Price

€35.80

Market Cap

€1.9b

7D

-1.4%

1Y

-20.0%

Updated

21 Jun, 2024

Data

Company Financials +

DMP Stock Overview

Manufactures and sells off-patent branded pharmaceutical products in Germany and internationally.

DMP fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance2/6
Financial Health3/6
Dividends3/6

Dermapharm Holding SE Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dermapharm Holding
Historical stock prices
Current Share Price€35.80
52 Week High€49.48
52 Week Low€30.80
Beta1.08
11 Month Change-3.50%
3 Month Change7.12%
1 Year Change-20.02%
33 Year Change-47.70%
5 Year Change18.15%
Change since IPO37.69%

Recent News & Updates

It Looks Like Dermapharm Holding SE's (ETR:DMP) CEO May Expect Their Salary To Be Put Under The Microscope

Jun 21
It Looks Like Dermapharm Holding SE's (ETR:DMP) CEO May Expect Their Salary To Be Put Under The Microscope

These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively

Apr 29
These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively

Recent updates

It Looks Like Dermapharm Holding SE's (ETR:DMP) CEO May Expect Their Salary To Be Put Under The Microscope

Jun 21
It Looks Like Dermapharm Holding SE's (ETR:DMP) CEO May Expect Their Salary To Be Put Under The Microscope

These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively

Apr 29
These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively

Dermapharm Holding SE's (ETR:DMP) Price In Tune With Earnings

Feb 07
Dermapharm Holding SE's (ETR:DMP) Price In Tune With Earnings

Dermapharm Holding (ETR:DMP) Seems To Use Debt Quite Sensibly

Dec 15
Dermapharm Holding (ETR:DMP) Seems To Use Debt Quite Sensibly

An Intrinsic Calculation For Dermapharm Holding SE (ETR:DMP) Suggests It's 24% Undervalued

Nov 17
An Intrinsic Calculation For Dermapharm Holding SE (ETR:DMP) Suggests It's 24% Undervalued

Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet

Aug 28
Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet

Dermapharm Holding SE's (ETR:DMP) Intrinsic Value Is Potentially 76% Above Its Share Price

Aug 01
Dermapharm Holding SE's (ETR:DMP) Intrinsic Value Is Potentially 76% Above Its Share Price

Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet

May 29
Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet

Is Dermapharm Holding SE (ETR:DMP) Trading At A 44% Discount?

May 03
Is Dermapharm Holding SE (ETR:DMP) Trading At A 44% Discount?

Dermapharm Holding's (ETR:DMP) Soft Earnings Are Actually Better Than They Appear

Apr 04
Dermapharm Holding's (ETR:DMP) Soft Earnings Are Actually Better Than They Appear

We Think Dermapharm Holding (ETR:DMP) Can Stay On Top Of Its Debt

Feb 22
We Think Dermapharm Holding (ETR:DMP) Can Stay On Top Of Its Debt

Is Dermapharm Holding (ETR:DMP) A Risky Investment?

Nov 17
Is Dermapharm Holding (ETR:DMP) A Risky Investment?

Is Dermapharm Holding (ETR:DMP) A Risky Investment?

Aug 16
Is Dermapharm Holding (ETR:DMP) A Risky Investment?

Is Dermapharm Holding (ETR:DMP) A Risky Investment?

May 18
Is Dermapharm Holding (ETR:DMP) A Risky Investment?

Is Dermapharm Holding (ETR:DMP) Using Too Much Debt?

Feb 17
Is Dermapharm Holding (ETR:DMP) Using Too Much Debt?

These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Reasonably Well

Nov 19
These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Reasonably Well

Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?

Aug 21
Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?

Is Dermapharm Holding SE (ETR:DMP) Trading At A 28% Discount?

Jul 31
Is Dermapharm Holding SE (ETR:DMP) Trading At A 28% Discount?

Is Dermapharm Holding SE (ETR:DMP) The Right Choice For A Smart Dividend Investor?

May 03
Is Dermapharm Holding SE (ETR:DMP) The Right Choice For A Smart Dividend Investor?

Calculating The Intrinsic Value Of Dermapharm Holding SE (ETR:DMP)

Apr 16
Calculating The Intrinsic Value Of Dermapharm Holding SE (ETR:DMP)

Here's Why Dermapharm Holding (ETR:DMP) Can Manage Its Debt Responsibly

Mar 25
Here's Why Dermapharm Holding (ETR:DMP) Can Manage Its Debt Responsibly

Did You Miss Dermapharm Holding's (ETR:DMP) Impressive 110% Share Price Gain?

Mar 07
Did You Miss Dermapharm Holding's (ETR:DMP) Impressive 110% Share Price Gain?

Is Dermapharm Holding SE's (ETR:DMP) 27% ROE Better Than Average?

Feb 15
Is Dermapharm Holding SE's (ETR:DMP) 27% ROE Better Than Average?

Something To Consider Before Buying Dermapharm Holding SE (ETR:DMP) For The 1.4% Dividend

Jan 29
Something To Consider Before Buying Dermapharm Holding SE (ETR:DMP) For The 1.4% Dividend

Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?

Dec 24
Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?

The Dermapharm Holding (ETR:DMP) Share Price Has Gained 45% And Shareholders Are Hoping For More

Dec 07
The Dermapharm Holding (ETR:DMP) Share Price Has Gained 45% And Shareholders Are Hoping For More

Dermapharm Holding SE Just Missed Earnings - But Analysts Have Updated Their Models

Nov 18
Dermapharm Holding SE Just Missed Earnings - But Analysts Have Updated Their Models

Shareholder Returns

DMPDE PharmaceuticalsDE Market
7D-1.4%-3.2%0.09%
1Y-20.0%-15.7%3.1%

Return vs Industry: DMP underperformed the German Pharmaceuticals industry which returned -15.6% over the past year.

Return vs Market: DMP underperformed the German Market which returned 2.9% over the past year.

Price Volatility

Is DMP's price volatile compared to industry and market?
DMP volatility
DMP Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement4.9%
10% most volatile stocks in DE Market10.6%
10% least volatile stocks in DE Market2.5%

Stable Share Price: DMP has not had significant price volatility in the past 3 months.

Volatility Over Time: DMP's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19913,497Hans-Georg Feldmeierir.dermapharm.de

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription healthcare products, herbal extracts, and other pharmaceutical products.

Dermapharm Holding SE Fundamentals Summary

How do Dermapharm Holding's earnings and revenue compare to its market cap?
DMP fundamental statistics
Market cap€1.93b
Earnings (TTM)€56.58m
Revenue (TTM)€1.13b

34.1x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DMP income statement (TTM)
Revenue€1.13b
Cost of Revenue€438.33m
Gross Profit€690.97m
Other Expenses€634.38m
Earnings€56.58m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 14, 2024

Earnings per share (EPS)1.05
Gross Margin61.19%
Net Profit Margin5.01%
Debt/Equity Ratio175.3%

How did DMP perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

84%

Payout Ratio

Does DMP pay a reliable dividends?

See DMP dividend history and benchmarks
When do you need to buy DMP by to receive an upcoming dividend?
Dermapharm Holding dividend dates
Ex Dividend DateJun 28 2024
Dividend Pay DateJul 02 2024
Days until Ex dividend5 days
Days until Dividend pay date9 days

Does DMP pay a reliable dividends?

See DMP dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.